Publizoom

Award notice Supplies

Produkty farmaceutyczne

Notice published in Polish. The AI analysis summarises it for you in your language.

Public buyer
Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy
Otwock
Place of performance
Otwock
Planned end of contract
7 September 2027
likely re-tender around March 2027
Bids received
6
Procedure
Open procedure
Any company may submit a bid.
Publication
16 September 2026
Notice language
Polish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Produkty farmaceutyczne - 14 pakietów

Awarded to

14 lots

  • Tislelizumab
  • Serplulimab
  • Tremelimumab
  • Ipilimumab
  • Ozymertynib
  • Amivantamab
  • Lazertinib
  • Binimetinim
  • Encoafenib
  • Nitendanib
  • Cemiplimab
  • Durvalumab
  • Entrektynib
  • Vincristina

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Similar contracts already awarded

ContractWinnerAmount
Produkty farmaceutyczne - płyny
Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy · 16 October 2026
Aesculap Chifa sp. z o.o. –
Produkty farmaceutyczne
Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy · 11 September 2026
Tramco Sp. z o.o.
Roche Polska Sp. z o.o.
Genesis Pharm sp. z o.o.
Takieda Pharma sp. z o.o.
Lek S.A.
Amgen sp. z o.o.
Bialmed Sp. z o.o.
Urtica Sp. z o.o.
Salus International Sp. z o.o.
Asclepios SA
–
Produkty farmaceutyczne
Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy · 26 August 2026
Urtica Sp. z o.o.
Farmacol-Logistyka Sp. z o.o.
Salus International Sp. z o.o.
Delfarma Sp.z o.o.
Asclepios SA
–
Produkty farmaceutyczne
Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy · 25 August 2026
Salus International Sp. z o.o.
Asclepios SA
Farmacol-Logistyka Sp. z o.o.
Urtica Sp. z o.o.
Bialmed Sp. z o.o.
Tramco Sp. z o.o.
Neuca s.a.
Baxter Polska sp. z o.o.
–
Produkty farmaceutyczne
Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy · 25 August 2026
Lek S.A.
Servier Polska Services Sp. z o.o.
Bialmed Sp. z o.o.
Salus International Sp. z o.o.
Asclepios SA
Neuca S.A.
Komtur Polska Sp. z o. o.
Farmacol-Logistyka Sp. z o.o.
Delfarma Sp.z o.o.
Urtica Sp. z o.o.
–

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 636871-2026.